Lead Healthcare has successfully raised financing provided by Rabobank

December 2019 — Lead Healthcare has successfully raised financing provided by Rabobank.

Lead Healthcare is a non-typical secondment company active in the healthcare sector and is the parent company of the labels PharmaLead Healthcare B.V. and, since 2019, MediLead Healthcare B.V.

Our role in the transaction

Oaklins' debt advisory team in the Netherlands advised Lead Healthcare in this fundraising.

Service

Funding, debt advisory & ECM

Parties

Talk to the deal team

Bas Stoetzer

Partner

Amsterdam, Netherlands
Oaklins Netherlands

View profile Get in touch

Joris Gijsbers

Associate Director

Amsterdam, Netherlands
Oaklins Netherlands

View profile Get in touch

Related deals

Life & Mobility has attracted investor Bolster Investment Partners

Private Equity | Healthcare

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.

Learn more

Asana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital

Healthcare

Asana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital

Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.

Learn more

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors

Private Equity | Healthcare

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners and co-investors

Laboratoires Herbolistique has received a majority investment from Yotta Capital Partners alongside co-investors Ouest Croissance, Sodero and CE IDF, with Bpifrance, Océans Participations and the management team reinvesting.

Learn more